Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10
Published March 11, 2015 · Recall initiated: February 23, 2015
Summary
FDA records drug Class II recall D-0399-2015, published March 11, 2015 and initiated February 23, 2015. Recalling firm: Sagent Pharmaceuticals Inc; Status: Terminated; Reported quantity: 140,850 vials; Lot: Lot Numbers: VATB012, VATB013, VATB014, Exp 11/15; VATB017, Exp 08/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sagent Pharmaceuticals Inc
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot Numbers: VATB012, VATB013, VATB014, Exp 11/15; VATB017, Exp 08/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.May 31, 2023
- FDANafcillin for Injection, USP, 1 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.May 31, 2023
- FDANafcillin for Injection, USP, 10 gram per Pharmacy Bulk Package, Rx only, Mfd. for SAGENT Pharmaceuticals,May 31, 2023
- FDAHeparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For IntravenousMarch 15, 2023
- FDADextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by:March 11, 2015
- FDAOxecta(TM) (oxycodone HCl) tablets, 5 mg, 100 count bottles, Rx only, Manufactured and Distributed by: KingMarch 11, 2015
Questions about this recall
Was Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10 recalled?
Yes. FDA published recall D-0399-2015 on March 11, 2015. Reported hazard: Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Letter